Moderna MRNA announced fourth-quarter 2024 results. Though earnings and sales beat estimates, both metrics declined ...
Robert Reich has termed Donald Trump's taxation policies as an "absolutely shameless giveaway," that could shoot up deficit ...
Genmab's Q4 2024 results impress with $897.4M revenue and 29% growth. GMAB's balance sheet is strong with nearly $3 billion ...
In a report released today, Andrew Boone from JMP Securities reiterated a Buy rating on Wix (WIX – Research Report), with a price target of ...
23h
Hosted on MSNIs This Dividend Stock a Buy After Better-Than-Expected Q4 Results?Pfizer (PFE) is a pharmaceutical and biotechnology company valued at $145 billion by market capitalization. While the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results